Pages that link to "Item:Q1042733"
From MaRDI portal
The following pages link to On optimal delivery of combination therapy for tumors (Q1042733):
Displaying 50 items.
- Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy (Q264091) (← links)
- Dynamics and optimal control of chemotherapy for low grade gliomas: insights from a mathematical model (Q321717) (← links)
- Dynamical analysis of chemotherapy models with time-dependent infusion (Q332394) (← links)
- Local controllability and optimal control for a model of combined anticancer therapy with control delays (Q335260) (← links)
- The nature of Hopf bifurcation for the Gompertz model with delays (Q409877) (← links)
- Structural stability investigation of bang-singular-bang optimal controls (Q415388) (← links)
- Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments (Q415424) (← links)
- On strategies on a mathematical model for leukemia therapy (Q425937) (← links)
- A survey of optimization models on cancer chemotherapy treatment planning (Q478056) (← links)
- Catalog of the optimal controls in cancer chemotherapy for the Gompertz model depending on PK/PD and the integral constraint (Q478655) (← links)
- A generalization of Gompertz law compatible with the Gyllenberg-Webb theory for tumour growth (Q543860) (← links)
- Analysis of the Hopf bifurcation for the family of angiogenesis models (Q549750) (← links)
- Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function (Q630983) (← links)
- Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics (Q662618) (← links)
- Maximization of viability time in a mathematical model of cancer therapy (Q680444) (← links)
- On probabilistic certification of combined cancer therapies using strongly uncertain models (Q739722) (← links)
- Analysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delays (Q902503) (← links)
- Optimal control of vibration-based micro-energy harvesters (Q1626543) (← links)
- Spreading speeds for a two-species competition-diffusion system (Q1678251) (← links)
- Sensitivity of combined chemo- and antiangiogenic therapy results in different models describing cancer growth (Q1678296) (← links)
- Optimization of combined leukemia therapy by finite-dimensional optimal control modeling (Q1682981) (← links)
- Closed-loop control of tumor growth by means of anti-angiogenic administration (Q1714906) (← links)
- Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruning'' (Q1716206) (← links)
- Optimal combined radio- and anti-angiogenic cancer therapy (Q1730431) (← links)
- Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors (Q1743540) (← links)
- Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers (Q1790751) (← links)
- Analysis of the effectiveness of the treatment of solid tumors in two cases of drug administration (Q1981126) (← links)
- Stochastic modelling of slow-progressing tumors: analysis and applications to the cell interplay and control of low grade gliomas (Q2004287) (← links)
- Optimization of an \textit{in vitro} chemotherapy to avoid resistant tumours (Q2013482) (← links)
- On the role of the objective in the optimization of compartmental models for biomedical therapies (Q2025280) (← links)
- On the role of pharmacometrics in mathematical models for cancer treatments (Q2026619) (← links)
- Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors (Q2033852) (← links)
- The stability analysis of tumor-immune responses to chemotherapy system driven by Gaussian colored noises (Q2128125) (← links)
- Noise and delay enhanced stability in tumor-immune responses to chemotherapy system (Q2137512) (← links)
- A deterministic and stochastic model for the system dynamics of tumor-immune responses to chemotherapy (Q2150394) (← links)
- Control strategies for a tumor-immune system with impulsive drug delivery under a random environment (Q2157877) (← links)
- Optimal control of cancer chemotherapy with delays and state constraints (Q2159444) (← links)
- Stability analysis of the family of tumour angiogenesis models with distributed time delays (Q2199481) (← links)
- Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures (Q2241959) (← links)
- Effect of treatment on the global dynamics of delayed pathological angiogenesis models (Q2341145) (← links)
- Analyzing the quality robustness of chemotherapy plans with respect to model uncertainties (Q2343800) (← links)
- On the preliminary design of hyperthermia treatments based on infusion and heating of magnetic nanofluids (Q2344604) (← links)
- Optimal chemotherapy schedules from tumor entropy (Q2398143) (← links)
- Mathematical modeling of the immune-chemotherapeutic treatment of breast cancer under some control parameters (Q2668824) (← links)
- An optimal control problem of immuno-chemotherapy in presence of gene therapy (Q2671158) (← links)
- Optimal control problems for differential equations applied to tumor growth: state of the art (Q2690605) (← links)
- Tumour growth control: analysis of alternative approaches (Q2693199) (← links)
- Optimisation of Cancer Drug Treatments Using Cell Population Dynamics (Q2820387) (← links)
- Tumor Development Under Combination Treatments with Anti-angiogenic Therapies (Q2820388) (← links)
- Therapy strategy in tumour cells and immune system interaction mathematical model (Q2825318) (← links)
